首页 > 最新文献

Monaldi Archives for Chest Disease最新文献

英文 中文
Prescription patterns and drug utilization in respiratory tract infections: implications for antimicrobial stewardship at a tertiary care teaching hospital. 呼吸道感染的处方模式和药物使用:对三级护理教学医院抗菌药物管理的影响。
IF 0.8 Q4 RESPIRATORY SYSTEM Pub Date : 2025-12-31 Epub Date: 2024-12-23 DOI: 10.4081/monaldi.2024.3196
Princy Domnic Dsouza, Sai Phalguna Prakash Chitralu, Chandrashekhar Mallikarjun Patil, Vinod Ashok Koujalagi, Sanatkumar Bharamu Nyamagoud

Respiratory tract infections (RTIs) are common causes of hospital admissions and are often treated with multiple medications, including antibiotics, contributing to antimicrobial resistance. Effective drug utilization evaluation (DUE) is essential for ensuring rational drug use in RTI management. This study aimed to assess prescription patterns and drug utilization in RTI patients at a tertiary care hospital, focusing on the rationality of drug use, polypharmacy, adherence to clinical guidelines, and implications for antimicrobial stewardship. A cross-sectional study was conducted at Vivekananda General Hospital, Hubballi, India, from August 2023 to January 2024. Data from 200 RTI inpatients, including demographics, medication types, administration routes, and prescription patterns, were analyzed. Descriptive and inferential statistics were used to evaluate adherence to guidelines and rational drug use. DUE revealed that 50.99% of patients were not prescribed cough syrup. Oral (52%) and intravenous (48%) routes were the most common. Budesonide was the most frequently prescribed bronchodilator (26.49%), and 72.45% of patients received oxygen. Ceftriaxone (12.68%) and azithromycin (11.88%) were the most commonly prescribed antibiotics. A high prevalence of polypharmacy was identified, with 39.50% of patients receiving more than three antibiotics, raising concerns about drug interactions and rationality. The study underscores the need for stricter adherence to clinical guidelines and targeted antimicrobial stewardship in RTI management. Enhanced DUE practices could improve patient outcomes and promote rational drug use.

呼吸道感染(RTIs)是住院的常见原因,通常需要多种药物治疗,包括抗生素,从而导致抗菌素耐药性。有效的药物利用评价(DUE)是RTI管理中确保合理用药的关键。本研究旨在评估一家三级医院RTI患者的处方模式和药物使用情况,重点关注药物使用的合理性、多种用药、临床指南的遵守情况以及对抗菌药物管理的影响。从2023年8月至2024年1月,在印度Hubballi的Vivekananda总医院进行了一项横断面研究。对200例RTI住院患者的人口统计学、药物类型、给药途径和处方模式等数据进行分析。使用描述性和推断性统计来评估指南的遵守情况和合理用药情况。DUE发现50.99%的患者没有开止咳糖浆。口服(52%)和静脉(48%)途径最为常见。布地奈德是最常用的支气管扩张剂(26.49%),72.45%的患者接受吸氧。头孢曲松(12.68%)和阿奇霉素(11.88%)是最常用的抗生素。多种用药的发生率较高,39.50%的患者使用3种以上抗生素,引起了对药物相互作用和合理性的担忧。该研究强调了在RTI管理中需要更严格地遵守临床指南和有针对性的抗菌药物管理。加强DUE实践可以改善患者预后并促进合理用药。
{"title":"Prescription patterns and drug utilization in respiratory tract infections: implications for antimicrobial stewardship at a tertiary care teaching hospital.","authors":"Princy Domnic Dsouza, Sai Phalguna Prakash Chitralu, Chandrashekhar Mallikarjun Patil, Vinod Ashok Koujalagi, Sanatkumar Bharamu Nyamagoud","doi":"10.4081/monaldi.2024.3196","DOIUrl":"10.4081/monaldi.2024.3196","url":null,"abstract":"<p><p>Respiratory tract infections (RTIs) are common causes of hospital admissions and are often treated with multiple medications, including antibiotics, contributing to antimicrobial resistance. Effective drug utilization evaluation (DUE) is essential for ensuring rational drug use in RTI management. This study aimed to assess prescription patterns and drug utilization in RTI patients at a tertiary care hospital, focusing on the rationality of drug use, polypharmacy, adherence to clinical guidelines, and implications for antimicrobial stewardship. A cross-sectional study was conducted at Vivekananda General Hospital, Hubballi, India, from August 2023 to January 2024. Data from 200 RTI inpatients, including demographics, medication types, administration routes, and prescription patterns, were analyzed. Descriptive and inferential statistics were used to evaluate adherence to guidelines and rational drug use. DUE revealed that 50.99% of patients were not prescribed cough syrup. Oral (52%) and intravenous (48%) routes were the most common. Budesonide was the most frequently prescribed bronchodilator (26.49%), and 72.45% of patients received oxygen. Ceftriaxone (12.68%) and azithromycin (11.88%) were the most commonly prescribed antibiotics. A high prevalence of polypharmacy was identified, with 39.50% of patients receiving more than three antibiotics, raising concerns about drug interactions and rationality. The study underscores the need for stricter adherence to clinical guidelines and targeted antimicrobial stewardship in RTI management. Enhanced DUE practices could improve patient outcomes and promote rational drug use.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142878645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of health-related quality of life in respiratory disease patients in a tertiary care teaching hospital. 评估一家三级教学医院呼吸系统疾病患者的健康相关生活质量。
IF 0.8 Q4 RESPIRATORY SYSTEM Pub Date : 2025-12-31 Epub Date: 2024-11-28 DOI: 10.4081/monaldi.2024.3146
Princy Domnic Dsouza, Sai Phalguna Prakash Chitralu, Vinod Ashok Koujalagi, Chandrashekhar Mallikarjun Patil, Sanatkumar Bharamu Nyamagoud, Agadi Hiremath Viswanatha Swamy

In India, respiratory tract infections (RTIs) are a significant public health concern, particularly among children and the elderly. The quality of life (QoL) of patients is greatly impacted by RTIs. Enhancing patient care and treatment approaches requires an understanding of the variables that influence health-related QoL (HRQoL). Our study's goal was to assess patients' HRQoL using the St. George Respiratory Questionnaire (SGRQ) in those with respiratory diseases. A cross-sectional observational study was carried out in the inpatient department of Vivekananda Hospital, Hubli, over 6 months from August 1, 2023, to January 31, 2024. After fulfilling the inclusion requirements, 200 people were included in the study. In 200 patients, while assessing the QoL, we found a significant correlation between age, diagnosis, some biomarkers, smoking, days of hospitalization, the severity of disease, residency, antibiotics, income, and education with HRQoL using SGRQ questionnaires. Our study highlights that HRQoL is impaired in patients with RTIs. Age was positively correlated with symptoms, activity, and impact, especially the ages of 55-69 years and 70-84 years. No correlation was found between gender, comorbidities, and alcohol consumption. Higher C-reactive protein and erythrocyte sedimentation rate levels were associated with greater impact and activity limitations. Our research concluded that several factors might impact a patient's HRQoL with respiratory disease. Determining these factors in advance can help identify individuals who are more likely to have poorer HRQoL and make interventions that could improve patient outcomes.

在印度,呼吸道感染 (RTI) 是一个重大的公共卫生问题,尤其是在儿童和老年人中。患者的生活质量(QoL)受到 RTI 的极大影响。要改善患者护理和治疗方法,就必须了解影响健康相关生活质量(HRQoL)的变量。我们的研究目标是使用圣乔治呼吸问卷(SGRQ)评估呼吸系统疾病患者的 HRQoL。从 2023 年 8 月 1 日至 2024 年 1 月 31 日的 6 个月期间,我们在胡布利维韦卡南达医院的住院部开展了一项横断面观察研究。符合纳入要求的 200 人被纳入研究。在对 200 名患者的 QoL 进行评估时,我们发现年龄、诊断、某些生物标志物、吸烟、住院天数、疾病严重程度、居住地、抗生素、收入和教育程度与使用 SGRQ 问卷的 HRQoL 之间存在显著相关性。我们的研究表明,RTI 患者的 HRQoL 受到了损害。年龄与症状、活动和影响呈正相关,尤其是 55-69 岁和 70-84 岁的患者。性别、合并症和饮酒量之间没有相关性。较高的 C 反应蛋白和红细胞沉降率水平与较大的影响和活动限制有关。我们的研究得出结论,有几个因素可能会影响呼吸系统疾病患者的 HRQoL。提前确定这些因素有助于确定哪些人更有可能出现较差的 HRQoL,并进行干预以改善患者的预后。
{"title":"Evaluation of health-related quality of life in respiratory disease patients in a tertiary care teaching hospital.","authors":"Princy Domnic Dsouza, Sai Phalguna Prakash Chitralu, Vinod Ashok Koujalagi, Chandrashekhar Mallikarjun Patil, Sanatkumar Bharamu Nyamagoud, Agadi Hiremath Viswanatha Swamy","doi":"10.4081/monaldi.2024.3146","DOIUrl":"10.4081/monaldi.2024.3146","url":null,"abstract":"<p><p>In India, respiratory tract infections (RTIs) are a significant public health concern, particularly among children and the elderly. The quality of life (QoL) of patients is greatly impacted by RTIs. Enhancing patient care and treatment approaches requires an understanding of the variables that influence health-related QoL (HRQoL). Our study's goal was to assess patients' HRQoL using the St. George Respiratory Questionnaire (SGRQ) in those with respiratory diseases. A cross-sectional observational study was carried out in the inpatient department of Vivekananda Hospital, Hubli, over 6 months from August 1, 2023, to January 31, 2024. After fulfilling the inclusion requirements, 200 people were included in the study. In 200 patients, while assessing the QoL, we found a significant correlation between age, diagnosis, some biomarkers, smoking, days of hospitalization, the severity of disease, residency, antibiotics, income, and education with HRQoL using SGRQ questionnaires. Our study highlights that HRQoL is impaired in patients with RTIs. Age was positively correlated with symptoms, activity, and impact, especially the ages of 55-69 years and 70-84 years. No correlation was found between gender, comorbidities, and alcohol consumption. Higher C-reactive protein and erythrocyte sedimentation rate levels were associated with greater impact and activity limitations. Our research concluded that several factors might impact a patient's HRQoL with respiratory disease. Determining these factors in advance can help identify individuals who are more likely to have poorer HRQoL and make interventions that could improve patient outcomes.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142741177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and predictors of suboptimal peak inspiratory flow rates in the management of chronic obstructive pulmonary disease. 慢性阻塞性肺疾病管理中次理想峰值吸气流量的患病率和预测因素
IF 0.8 Q4 RESPIRATORY SYSTEM Pub Date : 2025-12-31 Epub Date: 2024-12-24 DOI: 10.4081/monaldi.2024.3210
Madhusmita Mohanty Mohapatra, Mahesh Babu Vemuri, Vinod Kumar Saka, Pratap Upadhya, Vishnukanth Govindharaj

This cross-sectional study aimed to investigate the role of peak inspiratory flow rate (PIFR) in the management of inhalation therapy for patients with chronic obstructive pulmonary disease (COPD). Conducted in the Department of Pulmonary Medicine at a tertiary care institute from July 2021 to January 2022, this study included a total of 351 patients who were clinically diagnosed with stable COPD and currently receiving inhaler therapy. Participants underwent comprehensive assessments that included demographic data collection, the use of the ABCD assessment tool to evaluate disease severity, the COPD Assessment Test (CAT) for quality of life measurement, and assessments for adherence to inhaler therapy and inhaler technique proficiency. The primary focus was on determining the prevalence of suboptimal PIFR and identifying associated demographic and clinical factors. The results indicated that 45% of the patients exhibited suboptimal PIFR, which is critical for effective medication delivery in COPD management. Analysis revealed several significant predictors of suboptimal PIFR: female gender, lower CAT scores, the type of inhaler device used, and a Modified Medical Research Council grade of ≥2, which indicates increased levels of breathlessness. These findings underscore the importance of assessing PIFR in COPD patients to ensure effective drug delivery. The study suggests that personalized inhaler device prescriptions tailored to individual PIFR can enhance treatment efficacy and improve overall management outcomes for COPD patients. By addressing factors contributing to suboptimal PIFR, healthcare providers can optimize inhalation therapy and ultimately improve patient quality of life.

本横断面研究旨在探讨峰值吸气流量(PIFR)在慢性阻塞性肺疾病(COPD)患者吸入治疗管理中的作用。该研究于2021年7月至2022年1月在某三级保健研究所肺医学系进行,共纳入351名临床诊断为稳定期COPD且目前正在接受吸入器治疗的患者。参与者接受了全面的评估,包括人口统计数据收集、使用ABCD评估工具评估疾病严重程度、COPD评估测试(CAT)测量生活质量,以及对吸入器治疗的依从性和吸入器技术熟练程度的评估。主要重点是确定次优PIFR的患病率,并确定相关的人口统计学和临床因素。结果表明,45%的患者表现出较低的PIFR,这对于COPD治疗中有效的药物递送至关重要。分析揭示了PIFR次优的几个重要预测因素:女性、较低的CAT评分、使用的吸入器装置类型,以及修订医学研究委员会评分≥2,这表明呼吸困难程度增加。这些发现强调了评估COPD患者PIFR以确保有效给药的重要性。该研究表明,针对个体PIFR量身定制的个性化吸入器处方可以提高COPD患者的治疗效果并改善总体管理结果。通过解决导致PIFR次优的因素,医疗保健提供者可以优化吸入治疗并最终改善患者的生活质量。
{"title":"Prevalence and predictors of suboptimal peak inspiratory flow rates in the management of chronic obstructive pulmonary disease.","authors":"Madhusmita Mohanty Mohapatra, Mahesh Babu Vemuri, Vinod Kumar Saka, Pratap Upadhya, Vishnukanth Govindharaj","doi":"10.4081/monaldi.2024.3210","DOIUrl":"10.4081/monaldi.2024.3210","url":null,"abstract":"<p><p>This cross-sectional study aimed to investigate the role of peak inspiratory flow rate (PIFR) in the management of inhalation therapy for patients with chronic obstructive pulmonary disease (COPD). Conducted in the Department of Pulmonary Medicine at a tertiary care institute from July 2021 to January 2022, this study included a total of 351 patients who were clinically diagnosed with stable COPD and currently receiving inhaler therapy. Participants underwent comprehensive assessments that included demographic data collection, the use of the ABCD assessment tool to evaluate disease severity, the COPD Assessment Test (CAT) for quality of life measurement, and assessments for adherence to inhaler therapy and inhaler technique proficiency. The primary focus was on determining the prevalence of suboptimal PIFR and identifying associated demographic and clinical factors. The results indicated that 45% of the patients exhibited suboptimal PIFR, which is critical for effective medication delivery in COPD management. Analysis revealed several significant predictors of suboptimal PIFR: female gender, lower CAT scores, the type of inhaler device used, and a Modified Medical Research Council grade of ≥2, which indicates increased levels of breathlessness. These findings underscore the importance of assessing PIFR in COPD patients to ensure effective drug delivery. The study suggests that personalized inhaler device prescriptions tailored to individual PIFR can enhance treatment efficacy and improve overall management outcomes for COPD patients. By addressing factors contributing to suboptimal PIFR, healthcare providers can optimize inhalation therapy and ultimately improve patient quality of life.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142924046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Flexible bronchoscopy-assisted removal of aspirated scarf pins from the tracheobronchial tree: the experience of 146 subjects. 柔性支气管镜辅助清除气管支气管树上吸入的纱布针:146 名受试者的经验。
IF 0.8 Q4 RESPIRATORY SYSTEM Pub Date : 2025-12-31 Epub Date: 2024-10-25 DOI: 10.4081/monaldi.2024.3193
Sabah Ahmed Hussein, Hari Kishan Gonuguntla, Sarabon Tahura, Belgundi Preeti, Vishnu G Krishnan, Nitesh Gupta, Ahmed Al-Halfawy, Felix J Herth

Aspiration of scarf pins is a common problem in specific geographical locations where the Muslim population is high, especially in countries like Egypt, Bangladesh, Middle Eastern countries, and certain regions in India. This condition is also referred to as hijab-pin syndrome. We discuss the largest experience of flexible bronchoscopic extraction of aspirated scarf pins from the tracheobronchial tree. A multicenter retrospective observational study was conducted on 146 patients from 4 different centers in Egypt, Bangladesh, India, and Germany. Flexible bronchoscopy was successful in the extraction of aspirated scarf pins in all 146/146 patients with a 100% success rate. 136/146 (93.15%) patients were females, with the most common age group between 12 and 18 years (34.24%). 132/146 (90.4%) remembered the aspiration event before coming to the hospital. Cough was the predominant presenting symptom. (71.22%). In all 146 cases, the foreign body was identified on a standard chest X-ray. The left main bronchus was the most common site of aspiration, 67/146 (45.89%), followed by the right main bronchus, 56/146 (38.35%). 14 patients (9.58%) had a history of unsuccessful attempts to remove by rigid bronchoscopy, and flexible bronchoscopy was successful in these 14 (100%) patients who had a prior unsuccessful attempt to remove. The current series is the largest in literature and demonstrated an excellent success rate in the removal of the aspirated scarf pin.

在穆斯林人口较多的特定地区,尤其是埃及、孟加拉国、中东国家和印度的某些地区,头巾别针吸入是一个常见问题。这种情况也被称为头巾针综合征。我们讨论了通过柔性支气管镜从气管支气管树中取出吸入的头巾针的最大规模经验。我们对来自埃及、孟加拉国、印度和德国 4 个不同中心的 146 名患者进行了多中心回顾性观察研究。在所有 146/146 例患者中,柔性支气管镜均能成功取出吸入的巾钉,成功率为 100%。136/146(93.15%)例患者为女性,最常见的年龄组为 12 至 18 岁(34.24%)。132/146(90.4%)名患者在来医院之前记得吸入事件。咳嗽是最主要的症状。(71.22%).在所有 146 个病例中,异物都是在标准胸部 X 光检查中发现的。左主支气管是最常见的吸入部位,67/146(45.89%),其次是右主支气管,56/146(38.35%)。有 14 名患者(9.58%)曾尝试用硬质支气管镜切除气管但未成功,而柔性支气管镜在这 14 名(100%)曾尝试切除气管但未成功的患者中取得了成功。目前的系列研究是文献中规模最大的,显示了取出吸入巾针的极高成功率。
{"title":"Flexible bronchoscopy-assisted removal of aspirated scarf pins from the tracheobronchial tree: the experience of 146 subjects.","authors":"Sabah Ahmed Hussein, Hari Kishan Gonuguntla, Sarabon Tahura, Belgundi Preeti, Vishnu G Krishnan, Nitesh Gupta, Ahmed Al-Halfawy, Felix J Herth","doi":"10.4081/monaldi.2024.3193","DOIUrl":"10.4081/monaldi.2024.3193","url":null,"abstract":"<p><p>Aspiration of scarf pins is a common problem in specific geographical locations where the Muslim population is high, especially in countries like Egypt, Bangladesh, Middle Eastern countries, and certain regions in India. This condition is also referred to as hijab-pin syndrome. We discuss the largest experience of flexible bronchoscopic extraction of aspirated scarf pins from the tracheobronchial tree. A multicenter retrospective observational study was conducted on 146 patients from 4 different centers in Egypt, Bangladesh, India, and Germany. Flexible bronchoscopy was successful in the extraction of aspirated scarf pins in all 146/146 patients with a 100% success rate. 136/146 (93.15%) patients were females, with the most common age group between 12 and 18 years (34.24%). 132/146 (90.4%) remembered the aspiration event before coming to the hospital. Cough was the predominant presenting symptom. (71.22%). In all 146 cases, the foreign body was identified on a standard chest X-ray. The left main bronchus was the most common site of aspiration, 67/146 (45.89%), followed by the right main bronchus, 56/146 (38.35%). 14 patients (9.58%) had a history of unsuccessful attempts to remove by rigid bronchoscopy, and flexible bronchoscopy was successful in these 14 (100%) patients who had a prior unsuccessful attempt to remove. The current series is the largest in literature and demonstrated an excellent success rate in the removal of the aspirated scarf pin.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fibrotic outcomes from SARS-CoV-2 virus interstitial pneumonia. SARS-CoV-2 病毒间质性肺炎的纤维化后果
IF 0.8 Q4 RESPIRATORY SYSTEM Pub Date : 2025-12-31 Epub Date: 2024-10-16 DOI: 10.4081/monaldi.2024.3028
Luigi Pinto, Pietro Schino, Michele Bitetto, Ersilia Tedeschi, Michele Maiellari, Giancarlo De Leo, Elena Ludovico, Giovanni Larizza, Franco Mastroianni

Following the onset of the new COVID-19 pandemic, particular attention is paid to the long-term outcomes, especially concerning patients affected by the SARS-CoV-2 virus, leading to interstitial pneumonia. The aim of this research is to evaluate the possible evolution over time of interstitial pneumonia into post-inflammatory fibrosing interstitial disease. This research included 42 patients admitted to the COVID ward for SARS-CoV-2 interstitial pneumonia, 10 patients with mild pneumonia and respiratory failure who were treated with O2 only, 32 patients with severe pneumonia in whom O2 and non-invasive ventilation were used for respiratory assistance, and 4 patients treated with invasive mechanical ventilation. At 70±30 days, 6, 12, 24, and 36 months after discharge, the cohort of patients underwent the evaluation of inflammation indices, high-resolution computed tomography (CT) chest scans, and functional respiratory tests. The comparative analysis showed that 83.3% of patients had residual parenchymal lung disease at 36-month follow-up, with a significantly higher rate in those with severe pneumonia and more extensive disease on initial CT. Regarding the pulmonary involvement model, patients presented ground-glass opacity or peripheral parenchymal bands, or a combination of them, and peri- and intralobular interstitial thickening, which may be representative of fibrotic interstitial lung disease. There is a correlation between the severity of pneumonia, the inflammatory state, the need to increase respiratory support, and the quantity and persistence of CT-related lesions. Reductions in respiratory functions and exercise capacity were observed, the latter more pronounced in patients (24%) who had contracted severe pneumonia and required ventilatory support. Pulmonary outcomes from SARS-CoV-2 respiratory infections show a wide range of radiological findings, from complete recovery to stable outcomes of thickening and distortion of the interstitial architecture. From a functional point of view, there is an impairment of the alveolar-capillary diffusion capacity and, in cases of those who had contracted severe pneumonia, desaturation and reduced exercise tolerance in 24% of cases at a 36-month follow-up.

在新的 COVID-19 大流行开始后,人们特别关注其长期结果,尤其是受 SARS-CoV-2 病毒影响而导致间质性肺炎的患者。本研究的目的是评估间质性肺炎随着时间的推移可能演变成炎症后纤维化间质性疾病的情况。研究对象包括因 SARS-CoV-2 间质性肺炎入住 COVID 病房的 42 名患者,其中 10 名轻度肺炎和呼吸衰竭患者仅接受了氧气治疗,32 名重症肺炎患者使用了氧气和无创通气辅助呼吸,4 名患者接受了有创机械通气治疗。在出院后 70 天(±30 天)、6 个月、12 个月、24 个月和 36 个月,对患者进行了炎症指数评估、高分辨率计算机断层扫描(CT)胸部扫描和呼吸功能测试。对比分析显示,83.3%的患者在随访36个月时有残留肺实质病变,其中重症肺炎患者和初次CT显示病变范围更广的患者残留肺实质病变的比例明显更高。在肺部受累模型方面,患者表现为磨玻璃不透明或外周实质带,或两者结合,肺泡周围和肺泡内间质增厚,这可能是纤维化间质性肺病的代表。肺炎的严重程度、炎症状态、增加呼吸支持的必要性以及 CT 相关病变的数量和持续性之间存在相关性。SARS-CoV-2呼吸道感染造成的肺部结果显示出广泛的放射学结果,从完全康复到间质结构增厚和变形的稳定结果。从功能角度看,肺泡-毛细血管扩散能力受损,在感染重症肺炎的病例中,24%的病例在 36 个月的随访中出现饱和度下降和运动耐力降低。
{"title":"Fibrotic outcomes from SARS-CoV-2 virus interstitial pneumonia.","authors":"Luigi Pinto, Pietro Schino, Michele Bitetto, Ersilia Tedeschi, Michele Maiellari, Giancarlo De Leo, Elena Ludovico, Giovanni Larizza, Franco Mastroianni","doi":"10.4081/monaldi.2024.3028","DOIUrl":"10.4081/monaldi.2024.3028","url":null,"abstract":"<p><p>Following the onset of the new COVID-19 pandemic, particular attention is paid to the long-term outcomes, especially concerning patients affected by the SARS-CoV-2 virus, leading to interstitial pneumonia. The aim of this research is to evaluate the possible evolution over time of interstitial pneumonia into post-inflammatory fibrosing interstitial disease. This research included 42 patients admitted to the COVID ward for SARS-CoV-2 interstitial pneumonia, 10 patients with mild pneumonia and respiratory failure who were treated with O2 only, 32 patients with severe pneumonia in whom O2 and non-invasive ventilation were used for respiratory assistance, and 4 patients treated with invasive mechanical ventilation. At 70±30 days, 6, 12, 24, and 36 months after discharge, the cohort of patients underwent the evaluation of inflammation indices, high-resolution computed tomography (CT) chest scans, and functional respiratory tests. The comparative analysis showed that 83.3% of patients had residual parenchymal lung disease at 36-month follow-up, with a significantly higher rate in those with severe pneumonia and more extensive disease on initial CT. Regarding the pulmonary involvement model, patients presented ground-glass opacity or peripheral parenchymal bands, or a combination of them, and peri- and intralobular interstitial thickening, which may be representative of fibrotic interstitial lung disease. There is a correlation between the severity of pneumonia, the inflammatory state, the need to increase respiratory support, and the quantity and persistence of CT-related lesions. Reductions in respiratory functions and exercise capacity were observed, the latter more pronounced in patients (24%) who had contracted severe pneumonia and required ventilatory support. Pulmonary outcomes from SARS-CoV-2 respiratory infections show a wide range of radiological findings, from complete recovery to stable outcomes of thickening and distortion of the interstitial architecture. From a functional point of view, there is an impairment of the alveolar-capillary diffusion capacity and, in cases of those who had contracted severe pneumonia, desaturation and reduced exercise tolerance in 24% of cases at a 36-month follow-up.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142480437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical profile, risk factors, disease severity, and outcome for COVID-19 disease in patients with tuberculosis on treatment under the National Tuberculosis Elimination Program: a cohort of 1400 patients. 根据国家消除结核病计划接受治疗的结核病患者 COVID-19 疾病的临床概况、风险因素、疾病严重程度和预后:1400 名患者的队列。
IF 0.8 Q4 RESPIRATORY SYSTEM Pub Date : 2025-12-31 Epub Date: 2024-11-08 DOI: 10.4081/monaldi.2024.3103
Neeta Singla, Amitesh Gupta, U K Khalid, Ravindra Kumar Dewan, Rupak Singla

COVID-19 affected millions of people worldwide, and tuberculosis (TB) continues to affect millions of people each year. The combined pandemic of COVID-19 and TB had a catastrophic effect on healthcare policies and healthcare setups around the globe. The clinical profile and factors affecting the outcome of COVID-19 disease in TB patients on treatment in field conditions have not been studied in detail. The present study attempted to study the occurrence of COVID-19 among patients on TB treatment in terms of the severity of COVID-19 disease and outcome of both COVID-19 and TB in patients at National Tuberculosis Elimination Program treatment centers over a period of one year during peak COVID-19 times. Out of 1400 TB patients enrolled, 65 (5%) suffered from COVID-19 disease. Of the 65 TB patients with COVID-19 disease, 37 (57%) were male and under 45 years old, 33 (51%) had a TB diagnosis after first receiving a COVID-19 diagnosis, 29 (45%) had a TB diagnosis first and received anti-TB treatment before receiving a COVID-19 diagnosis, and only 3 patients (5%) had a COVID-19 and TB diagnosis concurrently. The majority of 59 (91%) patients had mild COVID-19 disease. The outcome of TB treatment was available in 25 patients out of these 65 COVID-19-positive patients, with 21 (84%) patients having a favorable outcome. Out of the 65 COVID-19-positive patients, 4/25 (16%) had unfavorable outcomes, with one patient (4%) failing TB treatment and two patients (8%) dying. This is the first study from India that studied the occurrence and course of COVID-19 among a large number of TB patients taking anti-TB treatment under programmatic conditions. Due to the similarity in symptoms of TB and certain viral respiratory illnesses, a protocol should be established for healthcare workers to check patients for both illnesses.

COVID-19 影响着全球数百万人,而结核病(TB)每年仍影响着数百万人。COVID-19 和结核病的联合大流行对全球的医疗政策和医疗机构造成了灾难性的影响。关于在野外条件下接受治疗的肺结核患者 COVID-19 疾病的临床概况和影响结果的因素,尚未进行详细研究。本研究试图从 COVID-19 疾病的严重程度以及 COVID-19 和肺结核在国家消除结核病计划治疗中心患者中的预后两个方面,研究在 COVID-19 高峰期一年内肺结核治疗患者中 COVID-19 的发生情况。在登记的 1400 名肺结核患者中,有 65 人(5%)患有 COVID-19 疾病。在 65 名患有 COVID-19 的肺结核患者中,37 人(57%)为男性,年龄在 45 岁以下;33 人(51%)在首次确诊 COVID-19 后又确诊了肺结核;29 人(45%)先确诊了肺结核,并在确诊 COVID-19 前接受了抗结核治疗;只有 3 人(5%)同时确诊了 COVID-19 和肺结核。59 名患者中的大多数(91%)患有轻度 COVID-19 疾病。在这 65 名 COVID-19 阳性患者中,有 25 名患者获得了结核病治疗结果,其中 21 名患者(84%)的治疗结果良好。在 65 名 COVID-19 阳性患者中,4/25(16%)人的治疗效果不佳,其中一名患者(4%)未能通过结核病治疗,两名患者(8%)死亡。这是印度首次在计划条件下研究大量接受抗结核治疗的肺结核患者中 COVID-19 的发生率和病程。由于肺结核和某些病毒性呼吸道疾病的症状相似,医疗机构应制定一套方案,对患者进行这两种疾病的检查。
{"title":"Clinical profile, risk factors, disease severity, and outcome for COVID-19 disease in patients with tuberculosis on treatment under the National Tuberculosis Elimination Program: a cohort of 1400 patients.","authors":"Neeta Singla, Amitesh Gupta, U K Khalid, Ravindra Kumar Dewan, Rupak Singla","doi":"10.4081/monaldi.2024.3103","DOIUrl":"10.4081/monaldi.2024.3103","url":null,"abstract":"<p><p>COVID-19 affected millions of people worldwide, and tuberculosis (TB) continues to affect millions of people each year. The combined pandemic of COVID-19 and TB had a catastrophic effect on healthcare policies and healthcare setups around the globe. The clinical profile and factors affecting the outcome of COVID-19 disease in TB patients on treatment in field conditions have not been studied in detail. The present study attempted to study the occurrence of COVID-19 among patients on TB treatment in terms of the severity of COVID-19 disease and outcome of both COVID-19 and TB in patients at National Tuberculosis Elimination Program treatment centers over a period of one year during peak COVID-19 times. Out of 1400 TB patients enrolled, 65 (5%) suffered from COVID-19 disease. Of the 65 TB patients with COVID-19 disease, 37 (57%) were male and under 45 years old, 33 (51%) had a TB diagnosis after first receiving a COVID-19 diagnosis, 29 (45%) had a TB diagnosis first and received anti-TB treatment before receiving a COVID-19 diagnosis, and only 3 patients (5%) had a COVID-19 and TB diagnosis concurrently. The majority of 59 (91%) patients had mild COVID-19 disease. The outcome of TB treatment was available in 25 patients out of these 65 COVID-19-positive patients, with 21 (84%) patients having a favorable outcome. Out of the 65 COVID-19-positive patients, 4/25 (16%) had unfavorable outcomes, with one patient (4%) failing TB treatment and two patients (8%) dying. This is the first study from India that studied the occurrence and course of COVID-19 among a large number of TB patients taking anti-TB treatment under programmatic conditions. Due to the similarity in symptoms of TB and certain viral respiratory illnesses, a protocol should be established for healthcare workers to check patients for both illnesses.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142629843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence, risk factors and clinical impact of burnout in internal medicine units: a call to action. 内科职业倦怠的流行率、风险因素和临床影响:行动呼吁。
IF 0.8 Q4 RESPIRATORY SYSTEM Pub Date : 2025-12-31 Epub Date: 2024-10-09 DOI: 10.4081/monaldi.2024.3069
Paola Gnerre, Ombretta Para, Dino Stefano Di Massimo, Tiziana Marcella Attardo, Dario Manfellotto, Francesco Dentali

Health workers, and in particular doctors and nurses working in internal medicine units (IMUs), are at high risk of burnout. Overcrowding, complexity and severity of clinical cases, patients' social and family issues, impact of death, and "workload" are all aspects that are specific risk factors that might lead to the development of burnout in this scenario. People suffering from burnout may face several psychological problems (including extreme physical and mental fatigue, emotional exhaustion, loss of enthusiasm concerning work, feelings of cynicism, and a low sense of personal accomplishment) and are also at risk of developing some somatic diseases. Furthermore, the quality of care delivered by a worker in burnout seems to worsen and slip down. In this review, we analyzed the main risk factors and consequences of burnout in IMUs, and we propose individual and organizational measures that may be applied to be able to prevent burnout in this setting.

医务工作者,尤其是在内科病房(IMU)工作的医生和护士,极易产生职业倦怠。在这种情况下,过度拥挤、临床病例的复杂性和严重性、病人的社会和家庭问题、死亡的影响以及 "工作量 "都是可能导致产生职业倦怠的特定风险因素。职业倦怠患者可能会面临一些心理问题(包括身心极度疲劳、情绪衰竭、对工作失去热情、愤世嫉俗、个人成就感低等),也有可能患上一些躯体疾病。此外,处于职业倦怠中的工作人员所提供的护理质量似乎会恶化和下降。在这篇综述中,我们分析了综管系统中职业倦怠的主要风险因素和后果,并提出了个人和组织可采用的措施,以防止在这种情况下出现职业倦怠。
{"title":"Prevalence, risk factors and clinical impact of burnout in internal medicine units: a call to action.","authors":"Paola Gnerre, Ombretta Para, Dino Stefano Di Massimo, Tiziana Marcella Attardo, Dario Manfellotto, Francesco Dentali","doi":"10.4081/monaldi.2024.3069","DOIUrl":"10.4081/monaldi.2024.3069","url":null,"abstract":"<p><p>Health workers, and in particular doctors and nurses working in internal medicine units (IMUs), are at high risk of burnout. Overcrowding, complexity and severity of clinical cases, patients' social and family issues, impact of death, and \"workload\" are all aspects that are specific risk factors that might lead to the development of burnout in this scenario. People suffering from burnout may face several psychological problems (including extreme physical and mental fatigue, emotional exhaustion, loss of enthusiasm concerning work, feelings of cynicism, and a low sense of personal accomplishment) and are also at risk of developing some somatic diseases. Furthermore, the quality of care delivered by a worker in burnout seems to worsen and slip down. In this review, we analyzed the main risk factors and consequences of burnout in IMUs, and we propose individual and organizational measures that may be applied to be able to prevent burnout in this setting.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142395179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quality of life, compliance with treatment, and challenges among patients undergoing cardiac intervention. 心脏介入治疗患者的生活质量、治疗依从性和挑战。
IF 0.8 Q4 RESPIRATORY SYSTEM Pub Date : 2025-12-31 Epub Date: 2024-12-04 DOI: 10.4081/monaldi.2024.3178
Shiv Kumar Mudgal, Ashis Ranjan, Vipin Patidar, Rakhi Gaur, Rajat Agarwal

Cardiovascular disease is the leading cause of mortality and disability worldwide, with important economic and quality-of-life implications. Effective treatment relies on drug adherence, which is impacted by a variety of factors; noncompliance increases morbidity, mortality, and healthcare costs. This study examines the quality of life, treatment adherence factors, and challenges that cardiac patients encounter during their treatment regimen. A cross-sectional study among 111 cardiac patients through purposive sampling was done at the All India Institute of Medical Sciences, Deoghar, between January 2023 and April 2024. Data on demographics, clinical characteristics, quality of life, and treatment adherence were gathered and analyzed using descriptive and inferential statistics while adhering to ethical guidelines and participant privacy. The research of 111 cardiac patients (76.6% male, mean age 56.45 years) revealed that the majority had undergone coronary artery bypass grafting surgery (83.8%), with many preferring private hospitals (58.6%). High medication adherence (82.0%) and regular follow-up (71.2%) were noted, although lifestyle improvements such as smoking cessation were less prevalent. Significant concerns about barriers were reported, including financial difficulties (35.1%) and accessibility of prescribed drugs (45.9%). Quality of life was generally reported as high, with most patients reporting no significant problem. This study reveals excellent adherence to medications and regular follow-up among participants. However, significant impediments such as financial constraints and accessibility issues for prescribed drugs continue to have an influence on treatment. Despite these limitations, patients often report a high quality of life, underscoring the complex interplay of medical, economic, and lifestyle aspects in cardiovascular health management.

心血管疾病是全世界死亡和残疾的主要原因,对经济和生活质量具有重要影响。有效的治疗依赖于药物依从性,这受到多种因素的影响;不遵守规定会增加发病率、死亡率和医疗成本。本研究考察了生活质量、治疗依从性因素和心脏病患者在治疗方案中遇到的挑战。在2023年1月至2024年4月期间,在Deoghar的全印度医学科学研究所,通过有目的的抽样对111名心脏病患者进行了横断面研究。在遵守伦理准则和参与者隐私的同时,使用描述性和推断性统计收集和分析了人口统计学、临床特征、生活质量和治疗依从性的数据。对111例心脏病患者(76.6%,平均年龄56.45岁)的研究显示,大多数患者接受过冠状动脉搭桥术(83.8%),许多患者更倾向于私立医院(58.6%)。高药物依从性(82.0%)和定期随访(71.2%)被注意到,尽管戒烟等生活方式的改善不那么普遍。据报告,对障碍的重大关切包括财政困难(35.1%)和处方药可及性(45.9%)。生活质量普遍较高,大多数患者报告没有明显问题。这项研究揭示了参与者对药物的良好依从性和定期随访。然而,财政限制和处方药物的可及性问题等重大障碍继续对治疗产生影响。尽管存在这些限制,但患者经常报告高质量的生活,强调了心血管健康管理中医疗,经济和生活方式方面的复杂相互作用。
{"title":"Quality of life, compliance with treatment, and challenges among patients undergoing cardiac intervention.","authors":"Shiv Kumar Mudgal, Ashis Ranjan, Vipin Patidar, Rakhi Gaur, Rajat Agarwal","doi":"10.4081/monaldi.2024.3178","DOIUrl":"10.4081/monaldi.2024.3178","url":null,"abstract":"<p><p>Cardiovascular disease is the leading cause of mortality and disability worldwide, with important economic and quality-of-life implications. Effective treatment relies on drug adherence, which is impacted by a variety of factors; noncompliance increases morbidity, mortality, and healthcare costs. This study examines the quality of life, treatment adherence factors, and challenges that cardiac patients encounter during their treatment regimen. A cross-sectional study among 111 cardiac patients through purposive sampling was done at the All India Institute of Medical Sciences, Deoghar, between January 2023 and April 2024. Data on demographics, clinical characteristics, quality of life, and treatment adherence were gathered and analyzed using descriptive and inferential statistics while adhering to ethical guidelines and participant privacy. The research of 111 cardiac patients (76.6% male, mean age 56.45 years) revealed that the majority had undergone coronary artery bypass grafting surgery (83.8%), with many preferring private hospitals (58.6%). High medication adherence (82.0%) and regular follow-up (71.2%) were noted, although lifestyle improvements such as smoking cessation were less prevalent. Significant concerns about barriers were reported, including financial difficulties (35.1%) and accessibility of prescribed drugs (45.9%). Quality of life was generally reported as high, with most patients reporting no significant problem. This study reveals excellent adherence to medications and regular follow-up among participants. However, significant impediments such as financial constraints and accessibility issues for prescribed drugs continue to have an influence on treatment. Despite these limitations, patients often report a high quality of life, underscoring the complex interplay of medical, economic, and lifestyle aspects in cardiovascular health management.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142786899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-world effectiveness and safety of handheld ultrasound in pleural procedures. 手持式超声波在胸膜手术中的实际效果和安全性。
IF 0.8 Q4 RESPIRATORY SYSTEM Pub Date : 2025-12-31 Epub Date: 2024-10-03 DOI: 10.4081/monaldi.2024.2992
Musaib Alavi, Waris Ali, Alaeddin Sagar, Majid Shafiq, Muhammad Azhar, Akbar S Ali, Moiz Salahuddin

The use of ultrasound for pleural procedures is associated with a decreased risk of complications. Handheld ultrasounds allow for easier evaluation of the pleural space. Limited data exists for the use of such devices for pleural procedures. The primary objective of our study was to assess the effectiveness and safety of handheld ultrasound for pleural procedures. We performed a prospective observational study, including all consecutive patients who underwent pleural procedures using the handheld ultrasound between September 2021 and November 2023. A total of 332 pleural procedures were attempted with handheld ultrasound, of which 329 pleural procedures (99.1%) were successfully performed. The median volume of fluid drained was 500 (interquartile range: 300-800). Thoracentesis was performed in 127 patients (38.5%), tube thoracostomy in 179 patients (54.4%), and medical thoracoscopy in 23 patients (7.0%). Exudative pleural effusions were found in 264 patients (80.0%), of which 152 (46.2%) were determined to be due to infectious etiologies. A total of 4 (1.2%) patients had a complication due to the procedure. 2 patients (0.6%) had a pneumothorax, while 2 patients (0.6%) developed a hemothorax. A total of 101 patients had either low platelets (<50×109/L) or use of antiplatelet or anticoagulant drugs. 128 patients (38.8%) were on positive pressure support during the pleural procedure. Our study shows that handheld ultrasounds are effective and safe for pleural procedures, including cases with septated pleural effusions and patients on antiplatelet or anticoagulant drugs.

使用超声波进行胸膜手术可降低并发症风险。手持式超声波可更方便地评估胸膜腔。将此类设备用于胸膜手术的数据有限。我们研究的主要目的是评估手持式超声波用于胸膜手术的有效性和安全性。我们进行了一项前瞻性观察研究,包括 2021 年 9 月至 2023 年 11 月期间使用手持式超声波进行胸膜手术的所有连续患者。共有 332 例胸膜手术尝试使用手持式超声波,其中 329 例胸膜手术(99.1%)成功实施。排液量中位数为 500(四分位间范围:300-800)。127名患者(38.5%)进行了胸腔穿刺术,179名患者(54.4%)进行了管式胸腔造口术,23名患者(7.0%)进行了内科胸腔镜检查。264名患者(80.0%)发现了渗出性胸腔积液,其中152名患者(46.2%)被确定为感染性病因所致。共有 4 名患者(1.2%)因手术出现并发症。2名患者(0.6%)出现气胸,2名患者(0.6%)出现血胸。共有 101 名患者出现血小板过低(0.5%)或血小板过高(0.5%)的情况。
{"title":"Real-world effectiveness and safety of handheld ultrasound in pleural procedures.","authors":"Musaib Alavi, Waris Ali, Alaeddin Sagar, Majid Shafiq, Muhammad Azhar, Akbar S Ali, Moiz Salahuddin","doi":"10.4081/monaldi.2024.2992","DOIUrl":"10.4081/monaldi.2024.2992","url":null,"abstract":"<p><p>The use of ultrasound for pleural procedures is associated with a decreased risk of complications. Handheld ultrasounds allow for easier evaluation of the pleural space. Limited data exists for the use of such devices for pleural procedures. The primary objective of our study was to assess the effectiveness and safety of handheld ultrasound for pleural procedures. We performed a prospective observational study, including all consecutive patients who underwent pleural procedures using the handheld ultrasound between September 2021 and November 2023. A total of 332 pleural procedures were attempted with handheld ultrasound, of which 329 pleural procedures (99.1%) were successfully performed. The median volume of fluid drained was 500 (interquartile range: 300-800). Thoracentesis was performed in 127 patients (38.5%), tube thoracostomy in 179 patients (54.4%), and medical thoracoscopy in 23 patients (7.0%). Exudative pleural effusions were found in 264 patients (80.0%), of which 152 (46.2%) were determined to be due to infectious etiologies. A total of 4 (1.2%) patients had a complication due to the procedure. 2 patients (0.6%) had a pneumothorax, while 2 patients (0.6%) developed a hemothorax. A total of 101 patients had either low platelets (<50×109/L) or use of antiplatelet or anticoagulant drugs. 128 patients (38.8%) were on positive pressure support during the pleural procedure. Our study shows that handheld ultrasounds are effective and safe for pleural procedures, including cases with septated pleural effusions and patients on antiplatelet or anticoagulant drugs.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142367412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peripheral pulmonary lesion: novel approaches in endoscopic guidance systems and a state-of-the-art review. 外周肺病变:内镜引导系统的新方法和最新的综述。
IF 0.8 Q4 RESPIRATORY SYSTEM Pub Date : 2025-12-31 Epub Date: 2024-12-20 DOI: 10.4081/monaldi.2024.3115
Filippo Lanfranchi, Lucio Michieletto

Diagnosis of peripheral pulmonary lesions (PPL) is the most challenging field in bronchoscopy and interventional pulmonology, which concerns early lung cancer diagnosis. Despite novel techniques and new approaches to the periphery of the lung, almost 25% of PPLs remain undiagnosed. Bronchoscopy with guide systems, virtual and/or electromagnetic navigation, robotic bronchoscopy, and transparenchymal nodule approaches tend to provide a higher percentage of reaching the lesion, but the diagnostic yield rarely exceeds 75%, regardless of the instruments used. Further studies are needed to evaluate what the main constraints of this discrepancy are and if a combined use of these techniques and instruments can provide an increased diagnostic yield.

肺外周病变(PPL)的诊断是支气管镜检查和介入肺学中最具挑战性的领域,关系到肺癌的早期诊断。尽管采用了新技术和新方法治疗肺外周,但仍有近25%的ppl未被诊断。有引导系统的支气管镜检查、虚拟和/或电磁导航、机器人支气管镜检查和透明肺结节入路往往提供更高的病变诊断率,但无论使用何种仪器,诊断率很少超过75%。需要进一步的研究来评估这种差异的主要制约因素是什么,以及这些技术和仪器的联合使用是否可以提高诊断率。
{"title":"Peripheral pulmonary lesion: novel approaches in endoscopic guidance systems and a state-of-the-art review.","authors":"Filippo Lanfranchi, Lucio Michieletto","doi":"10.4081/monaldi.2024.3115","DOIUrl":"10.4081/monaldi.2024.3115","url":null,"abstract":"<p><p>Diagnosis of peripheral pulmonary lesions (PPL) is the most challenging field in bronchoscopy and interventional pulmonology, which concerns early lung cancer diagnosis. Despite novel techniques and new approaches to the periphery of the lung, almost 25% of PPLs remain undiagnosed. Bronchoscopy with guide systems, virtual and/or electromagnetic navigation, robotic bronchoscopy, and transparenchymal nodule approaches tend to provide a higher percentage of reaching the lesion, but the diagnostic yield rarely exceeds 75%, regardless of the instruments used. Further studies are needed to evaluate what the main constraints of this discrepancy are and if a combined use of these techniques and instruments can provide an increased diagnostic yield.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142866193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Monaldi Archives for Chest Disease
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1